Sittner & Nelson’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$213K Sell
2,359
-91
-4% -$8.35K 0.08% 163
2025
Q4
$220K Sell
2,450
-59
-2% -$5.59K 0.08% 157
2025
Q3
$247K Sell
2,509
-66
-3% -$6.54K 0.09% 127
2025
Q2
$235K Buy
2,575
+443
+21% +$42.8K 0.09% 129
2025
Q1
$241K Buy
2,132
+400
+23% +$42.8K 0.1% 124
2024
Q4
$183K Sell
1,732
-353
-17% -$37.9K 0.08% 137
2024
Q3
$225K Buy
2,085
+801
+62% +$87.4K 0.1% 124
2024
Q2
$139K Sell
1,284
-399
-24% -$47K 0.07% 142
2024
Q1
$222K Buy
1,683
+1
+0.1% +$125 0.11% 111
2023
Q4
$205K Sell
1,682
-302
-15% -$33.7K 0.11% 109
2023
Q3
$223K Buy
1,984
+2
+0.1% +$254 0.13% 98
2023
Q2
$289K Buy
1,982
+1
+0.1% +$136 0.16% 91
2023
Q1
$256K Buy
1,981
+1
+0.1% +$126 0.15% 103
2022
Q4
$252K Sell
1,980
-2
-0.1% -$232 0.15% 103
2022
Q3
$207K Buy
1,982
+151
+8% +$16.6K 0.14% 107
2022
Q2
$192K Buy
1,831
+201
+12% +$23.8K 0.13% 105
2022
Q1
$209K Buy
1,630
+147
+10% +$17.7K 0.12% 100
2021
Q4
$183K Buy
1,483
+494
+50% +$64.7K 0.11% 108
2021
Q3
$140K Hold
989
0.09% 114
2021
Q2
$154K Buy
989
+1
+0.1% +$162 0.11% 102
2021
Q1
$154K Hold
988
0.11% 100
2020
Q4
$148K Buy
+988
New +$140K 0.13% 96

Other funds holding ZBH

Sittner & Nelson's ZBH Position: Q1 2026 in Review

Sittner & Nelson reduced its Zimmer Biomet (ZBH) stake by 3.7% in Q1 2026, selling an estimated $8.35K and leaving 2,359 shares worth $213K. The position accounts for 0.08% of the portfolio, ranked #163.

Sittner & Nelson first reported a position in ZBH in Q4 2020 and has held it in 22 quarters since. The position peaked at $289K in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Sittner & Nelson held 2,359 shares of Zimmer Biomet worth $213K as of Q1 2026.
  • Sittner & Nelson sold 91 Zimmer Biomet shares in Q1 2026, an estimated $8.35K.
  • Zimmer Biomet made up 0.08% of Sittner & Nelson's portfolio in Q1 2026, its #163 holding.
  • Sittner & Nelson first reported a position in Zimmer Biomet in Q4 2020 and has held it in 22 quarters since.
  • Sittner & Nelson's Zimmer Biomet position peaked at $289K in Q2 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Sittner & Nelson's 13F filing for Q1 2026, filed 12 May 2026.